Bristol-Myers Squibb Shares Fall After Leerink Partners Downgrade

MT newswire2026/10/05 19:35

03:35 PM EDT, 10/05/2026 (MT Newswires) -- Bristol-Myers Squibb (BMY) shares were down 4% in Monday trading after Leerink Partners downgraded the biopharmaceutical to market perform from outperform and adjusted its price target to $59 from $73. Intraday volume was 12.7 million shares, compared with the daily average of 11 million. Price: 58.65, Change: -2.50, Percent Change: -4.09

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35

Cathie Wood’s ARK Sells Bitcoin ETF, SpaceX and Robinhood Shares in Portfolio Shift

CoinEdition•2026/10/10 17:39